Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
16.9M
-
Number of holders
-
31
-
Total 13F shares, excl. options
-
4.02M
-
Shares change
-
+277K
-
Total reported value, excl. options
-
$4.95M
-
Value change
-
+$278K
-
Number of buys
-
13
-
Number of sells
-
-8
-
Price
-
$1.23
Significant Holders of Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) as of Q1 2025
34 filings reported holding MRKR - Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share as of Q1 2025.
Marker Therapeutics, Inc. - Common Stock, par value $0.001 per share (MRKR) has 31 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4.02M shares
of 16.9M outstanding shares and own 23.85% of the company stock.
Largest 10 shareholders include NEA Management Company, LLC (1.63M shares), Blue Owl Capital Holdings LP (554K shares), Hudson Bay Capital Management LP (500K shares), Aisling Capital Management LP (325K shares), VANGUARD GROUP INC (275K shares), Alyeska Investment Group, L.P. (262K shares), GEODE CAPITAL MANAGEMENT, LLC (88.7K shares), RENAISSANCE TECHNOLOGIES LLC (83.5K shares), LPL Financial LLC (73.2K shares), and Squarepoint Ops LLC (43.3K shares).
This table shows the top 31 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.